Skip to main content

Atossa Therapeutics, Inc.

ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001488039

No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Atossa Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
49
−5 vs. Q3 2023
Shares held
16.1M
−87.8K (−0.5%) vs. Q3 2023
Total value
$14.2M
+$2.29M (+19.3%) vs. Q3 2023
New holders
3
9 more added
Sold out
8
18 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ATOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 49 institutions
Q1 2021: 54 institutionsQ2 2021: 90 institutionsQ3 2021: 93 institutionsQ4 2021: 92 institutionsQ1 2022: 83 institutionsQ2 2022: 73 institutionsQ3 2022: 59 institutionsQ4 2022: 51 institutionsQ1 2023: 45 institutionsQ2 2023: 52 institutionsQ3 2023: 54 institutionsQ4 2023: 49 institutionsQ1 2024: 67 institutionsQ2 2024: 77 institutionsQ3 2024: 86 institutionsQ4 2024: 86 institutionsQ1 2025: 83 institutionsQ2 2025: 84 institutionsQ3 2025: 67 institutionsQ4 2025: 67 institutionsQ1 2026: 33 institutionsQ2 2026: 31 institutions
Value heldQ4 2023: $14.2M
Q1 2021: $22.8MQ2 2021: $225.8MQ3 2021: $102.1MQ4 2021: $64.2MQ1 2022: $45.4MQ2 2022: $25.4MQ3 2022: $15.8MQ4 2022: $9.49MQ1 2023: $11.9MQ2 2023: $20.2MQ3 2023: $11.9MQ4 2023: $14.2MQ1 2024: $37.4MQ2 2024: $31.2MQ3 2024: $41.8MQ4 2024: $28.3MQ1 2025: $19.1MQ2 2025: $17.7MQ3 2025: $16.9MQ4 2025: $13.0MQ1 2026: $6.52MQ2 2026: $2.60M
Institutions holding ATOS and their total value by quarter
QuarterHoldersValue
Q2 202631$2.60M
Q1 202633$6.52M
Q4 202567$13.0M
Q3 202567$16.9M
Q2 202584$17.7M
Q1 202583$19.1M
Q4 202486$28.3M
Q3 202486$41.8M
Q2 202477$31.2M
Q1 202467$37.4M
Q4 202349$14.2M
Q3 202354$11.9M
Q2 202352$20.2M
Q1 202345$11.9M
Q4 202251$9.49M
Q3 202259$15.8M
Q2 202273$25.4M
Q1 202283$45.4M
Q4 202192$64.2M
Q3 202193$102.1M
Q2 202190$225.8M
Q1 202154$22.8M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Atossa Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding ATOS in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc5,675,724$4.99M0.00%00.0%Unchanged
BlackRock Inc.2,796,437$2.46M0.00%−90,080−3.1%Reduced
Laurion Capital Management LP2,225,800$1.96M0.07%00.0%Unchanged
Renaissance Technologies LLC1,284,270$1.13M0.00%+41,900+3.4%Added
Geode Capital Management, LLC1,114,924$981.4K0.00%+12,348+1.1%Added
Gsa Capital Partners LLP449,082$395.0K0.03%+101,690+29.3%Added
State Street Corp436,271$383.9K0.00%00.0%Unchanged
Bank of Montreal352,700$359.8K0.00%+352,700New
Morgan Stanley229,612$202.1K0.00%+79,855+53.3%Added
Northern Trust Corp227,922$200.6K0.00%+13,280+6.2%Added
Susquehanna International Group, LLP204,945$180.4K0.00%−43,559−17.5%Reduced
Two Sigma Investments, LP161,320$142.0K0.00%−12,616−7.3%Reduced
Connor, Clark & Lunn Investment Management Ltd.120,328$105.9K0.00%−13,263−9.9%Reduced
Group One Trading, L.P.115,249$101.4K0.00%−15,486−11.8%Reduced
Mariner, LLC105,910$93.2K0.00%00.0%Unchanged
XTX Topco Ltd85,369$75.1K0.02%−82,058−49.0%Reduced
Squarepoint Ops LLC63,065$55.5K0.00%+63,065New
Bank of New York Mellon Corp52,217$46.0K0.00%−58,631−52.9%Reduced
Edmond de Rothschild Holding S.A.50,000$44.0K0.00%00.0%Unchanged
Millennium Management LLC47,271$41.6K0.00%−192,433−80.3%Reduced
LPL Financial LLC46,992$41.4K0.00%−3,000−6.0%Reduced
Charles Schwab Investment Management Inc45,962$40.4K0.00%00.0%Unchanged
Commonwealth Equity Services, LLC33,345$29.0K0.00%00.0%Unchanged
Regions Financial Corp30,000$26.4K0.00%+30,000New
Two Sigma Advisers, LP25,200$22.2K0.00%+3,900+18.3%Added
LVM Capital Management Ltd21,000$18.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.11,550$10.2K0.00%−2,197−16.0%Reduced
J. L. Bainbridge & Co., Inc.11,121$9.79K0.00%00.0%Unchanged
Raymond James Financial Services Advisors, Inc.10,815$9.52K0.00%−1,210−10.1%Reduced
Tower Research Capital LLC (TRC)10,749$9.46K0.00%−2,484−18.8%Reduced
Federation des caisses Desjardins du Quebec10,600$9.33K0.00%−2,000−15.9%Reduced
Atria Wealth Solutions, Inc.10,000$8.80K0.00%00.0%Unchanged
Citadel Advisors LLC9,140$8.04K0.00%−36,016−79.8%Reduced
BNP Paribas Arbitrage, SA4,555$4.01K0.00%00.0%Unchanged
FMR LLC4,163$3.66K0.00%−21−0.5%Reduced
Bank of America Corp2,116$1.86K0.00%+166+8.5%Added
Harbour Investments, Inc.1,711$1.51K0.00%00.0%Unchanged
St. Johns Investment Management Company, LLC1,550$1.36K0.00%00.0%Unchanged
Wells Fargo & Company910$8010.00%+42+4.8%Added
TD Waterhouse Canada Inc.700$6370.00%00.0%Unchanged
Allworth Financial LP702$6180.00%00.0%Unchanged
Castleview Partners, LLC500$4400.00%00.0%Unchanged
JPMorgan Chase & Co188$1660.00%+94+100.0%Added
Delos Wealth Advisors, LLC100$880.00%00.0%Unchanged
Clearstead Advisors, LLC70$620.00%−70−50.0%Reduced
Qube Research & Technologies Ltd54$480.00%00.0%Unchanged
UBS Group AG30$260.00%−33,329−99.9%Reduced
Royal Bank of Canada86$00.00%−108−55.7%Reduced
Hantz Financial Services, Inc.82$00.00%00.0%Unchanged
Virtu Financial LLC0$00.00%−80,728−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−36,466−100.0%Sold out
HRT Financial LP0$00.00%−29,138−100.0%Sold out
HighTower Advisors, LLC0$00.00%−20,100−100.0%Sold out
Jane Street Group, LLC0$00.00%−17,302−100.0%Sold out
Victory Capital Management Inc0$00.00%−13,823−100.0%Sold out
NBC Securities, Inc.0$00.00%−150−100.0%Sold out
Cutler Group LP0$00.00%−574−100.0%Sold out